University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 10 of 15
A Comparative Study of Subjects Past Their Final Follow-ON Visit
NCT03071835
Beta-alanine and Elder Endurance
NCT02821481
Miami Membrane for Potency (MMEP) Trial
NCT02710422
The Effect of an RBAC Supplement (BRM4) on NAFLD
NCT02568787
Parent-Child Early Approaches to Raising Language Skills (PEARLS) Intervention
NCT03260062
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
NCT02416102
Addressing Colorectal Cancer in South Florida Firefighters
NCT05976282
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention
NCT02696681
Carpal Tunnel/Amyloidosis Blood Sample Study
NCT02587728
Aspirin and Enoxaparin for VTE in Trauma
NCT02396732
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
NCT02145390
Community Study of Outcome Monitoring for Emotional Disorders in Teens
NCT02567266
Injection Pressure & Adductor Canal Block
NCT02563990
Striving Towards EmPowerment and Medication Adherence (STEP-AD)
NCT02764853
QOL Outcomes in CRS With Polyps
NCT03144375
Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
NCT02507336
Vestibular Testing: Consistency and Effects Over Time
NCT03182868
Remote Ischemic Limb Preconditioning In Healthy Volunteers
NCT02553655
Low Back Pain and Breathing Pattern Dysfunction
NCT02429752
HIV Prevention Toolkit for HIV-negative Male Couples
NCT02494817
Dapagliflozin Effects on Epicardial Fat
NCT02235298
JUEGA: A Fun Study for Hispanic/Latino Adolescent Girls
NCT02578147
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284
Characterization of CD Responders to Vedolizumab
NCT04909359
Prevention of Parastomal Hernia by Mesh Placement
NCT02404545
Electromyography and Yoga
NCT02818881
Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention
NCT02511236
Suture Contamination Rate in Adjustable Suture Strabismus Surgery
NCT02424357
Enhanced Primary Care and Technology for Children With Chronic Disease
NCT02490566
DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy
NCT02663817
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease
NCT02121028
Testing mTBI in Athletes
NCT02486003
Healthy Caregivers-Healthy Children (HC2) Phase II
NCT02697565
Study of TCP-ATRA for Adult Patients With AML and MDS
NCT02273102
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
NCT00356317
Mild and Rapidly Improving Stroke Study
NCT02072681
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
NCT02394665
Diet Study on Ulcerative Colitis
NCT04147598
Reducing Obesity Health Disparities in Hispanic Youth
NCT03943628
The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV
NCT02214173
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
NCT02202109
Multiplex Laser vs. PDL (Pulsed Dye Laser ) in the Treatment of Surgical Scars
NCT02472405
Hispanic Secondary Stroke Prevention Initiative
NCT02251834
MRI Based Active Selection for Treatment Trial
NCT02242773
The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke
NCT02272426
EZCast-DFU Study With Portal for Application of Topical Medications
NCT02131961
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
NCT02270645
Transcranial Direct Current Stimulation for Freezing of Gait
NCT02266004
Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding
NCT02306174
NAC Trial for Anosmia
NCT02481609
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.